New strategy aims to pinpoint who needs extra antibiotic for deadly blood infection
NCT ID NCT07155590
Summary
This research analyzes data from two previous trials to see if a patient classification system can identify which people with Staphylococcus aureus blood infections are most likely to benefit from adding the antibiotic fosfomycin to their standard treatment. The goal is to improve survival and treatment success by giving the extra drug only to patients who truly need it, rather than to everyone. The study involves analyzing data from 369 patients who were already part of earlier clinical trials.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for STAPHYLOCOCCAL AUREUS INFECTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hospital Universitari de Bellvitge
L'Hospitalet de Llobregat, Catalonia, 08907, Spain
-
Hospital Universitario Virgen de Macarena
Seville, 41009, Spain
Conditions
Explore the condition pages connected to this study.